Showing results (111-120 of 132) with videos related to
Sort By:
Pageof 14
Nature Communications|June 24, 2020
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumoursJoão M Fernandes Neto, Ernest Nadal, Evert Bosdriesz, et al.Nature Communications|December 2, 2025
Aberrant neural activity in the peritumoral cortex underlies the progression of tumor-associated seizuresBibi L J Bouwen, Anne Bolleboom, Yuanhong Tang, et al.Science Advances|October 18, 2023
BCRP drives intrinsic chemoresistance in chemotherapy-naïve breast cancer brain metastasisRebeca Uceda-Castro, Andreia S Margarido, Ji-Ying Song, et al.Cell Death Discovery|June 27, 2026
Histidine to glutamine substitutants, a regulated process that impacts cell survival and suggests histidine shortage in cancerDomenica Lovecchio, Pierre-René Körner, Lorenzo Valcanover, et al.The Journal of Clinical Investigation|November 3, 2007
Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolismAntonius E van Herwaarden, Els Wagenaar, Cornelia M M van der Kruijssen, et al.Molecular Oncology|January 18, 2023
Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinomaAntonio Mulero-Sánchez, Christel F A Ramirez, Aimée du Chatinier, et al.Plos One|September 6, 2022
Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activityZiva Pogacar, Jackie L Johnson, Lenno Krenning, et al.Cancer Research|May 7, 2026
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope ProductionRemco Nagel, Adva Kochavi, Karine Flem-Karlsen, et al.Pharmaceuticals (Basel, Switzerland)|January 8, 2025
A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for GlioblastomaIoannis Ntafoulis, Stijn L W Koolen, Olaf van Tellingen, et al.Neuro-Oncology|September 11, 2019
MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumorsMichaël H Meel, Miriam Guillén Navarro, Mark C de Gooijer, et al.Pageof 14